3894 J. Am. Chem. Soc., Vol. 118, No. 16, 1996
Schrock et al.
(AdN), 35.8 (AdN), 32.6 (CMe2Ph), 30.3 (CMe2Ph), 29.9 (CHEt2), 29.7
(AdN), 28.7 (CH2CH3), 27.0 (CH2CH3), 11.9 (CH2CH), 10.4 (CH2CH3);
19F NMR (CD2Cl2, -35 °C) δ -76.53, 76.78, 77.77. Anal. Calcd for
MoC36H44N2O2F12: C, 50.24; H, 5.15; N, 3.25. Found: C, 50.15; H,
5.55; N, 3.25.
Synthesis of Mo(NAd)(CHCMe2Ph)[OCH(CF3)2]2(quinuclidine)
(2d). To a 3 mL solution of 39 mg of 2a (0.047 mmol) in toluene was
added 26 mg of quinuclidine (0.24 mmol) at room temperature. All
solvents and excess quinuclidine were removed in vacuo after 1 h, and
the solid residue was recrystallized from 1 mL of pentane at -30 °C
to give 28 mg of off-white crystalline product (70%): 1H NMR (C6D6)
δ 12.81 (s, 1, CHCMe2Ph, JCH ) 119), 7.02-7.10 (m, 4, Ph), 6.92-
6.97 (m, 1, Ph), 6.13 (sept, 1, OCH(CF3)2, JFH ) 7.1), 4.26 (sept, 1,
OCH(CF3)2, JFH ) 6.3), 2.78 (m, 6, quinuclidine), 2.02 (br, 6, CH2),
1.89 (s, 6, CHMe2Ph), 1.45 (s, 6, CH2), 1.39 (br, 3, CH), 1.09 (m, 6,
quinuclidine), 0.93 (br, 6, quinuclidine).
140.8, 139.4, 130.1, 127.6, 127.5, 127.2, 127.0, 126.4, 125.8, 122.9,
83.9 (CMe2Ph), 75.5 (NAd), 43.4 (NAd), 41.8 (CMe2Ph), 35.7 (NAd,
29.8 (CMe2Ph), 29.7 (CMe2Ph), 29.4 (NAd), 27.8 (o-Me), 20.1 (p-
Me); 19F NMR (C6D6) δ -72.94, -73.20, -73.53, -73.95. Anal.
Calcd for MoC47H48N2O2F12: C, 56.63; H, 4.85; N, 2.81. Found: C,
56.58; H, 4.93; N, 2.58.
Synthesis of Mo(N-2,6-Me2C6H4)(CHCMe2Ph)(OC6F5)2(quinucli-
dine) (7). Two equivalents of KOC6F5 was added to a cold solution
(-40 °C) of 0.5 mol of [Mo(CHCMe2Ph)(N-2,6-Me2C6H4)(OSO2CF3)2-
(DME)] in 50 mL of THF. After 5 h at -40 °C, 1 equiv of quinuclidine
was added and the reaction mixture was stirred for 2 h at room
temperature. The solvents were evaporated in vacuo to give an orange
powder. The orange powder was extracted with a minimum amount
of toluene. The extract was filtered, and the solvents were removed
from the filtrate in vacuo. The crude product was recrystallized from
cold ether to give yields in the range 70-90%: 1H NMR (C6D6) δ
14.16 (s, 1, CHCMe2Ph anti, JCH ) 145 (from 13C satellites)), 13.02
(s, 1, CHCMe2Ph syn, JCH ) 115 (from 13C satellites)), 7.12-6.75 (m,
8, aromatic), 2.93 (m, 6, NCH2 anti), 2.75 (m, 6, NCH2 syn), 2.72 (s,
6, NMePh syn and anti), 1.95 (s, 3, CHCMeMe′Ph), 1.73 (s, 3,
CHCMeMe′Ph syn), 1.33 (s, 3, CHCMeMe′Ph anti), 1.10 (s, 3,
CHCMeMe′Ph syn), 1.00 (m, 1, NCH2CH2CH syn and anti), 0.89 (m,
6, NCH2CH2 syn and anti); 13C NMR δ 298.34 (CHCMe2Ph anti),
298.17 (d, J ) 117, CHCMe2Ph syn), 155.51 (Cipso CMe2Ph anti),
153.96 (Cipso CMe2Ph syn), 148.6-136.48 (m, OC6F5), 135.50 (Co NAr),
128.67-125.75 (aromatics), 53.80 (NCH2CH2 anti), 53.27 (NCH2CH2
syn), 52.60 (CMe2Ph syn), 51.47 (CMe2Ph anti), 31.06 (CMePh syn),
30.86 (CMePh anti), 28.71 (CMePh syn), 27.90 (CMePh anti), 25.69
(NCH2CH2 syn and anti), 20.67 (NMePh syn), 19.62 (NCH2CH2CH
syn and anti), 19.19 (NMePh anti). Anal. Calcd for C37H34-
MoN2F10O2: C, 53.89; H, 4.16; N, 3.40. Found: C, 53.84; H, 4.27;
N, 3.22.
Synthesis of Mo(NAd)[C(o-TMS-C6H4)(CHdCHCMe2Ph)][OCMe-
(CF3)2]2 (3a/b). A pentane solution (60 mL) of the compound
Mo(NAd)(CHCMe2Ph)[OCMe(CF3)2]2 (1.00 g, 1.35 mmol) was cooled
to -40 °C. To the cold yellow solution was added o-TMSPA (239
mg, 1.37 mmol). The mixture was then kept cold at -40 °C for 1/2 h.
During this period, the mixture assumed a deep red color. The red
solution was then filtered through Celite, concentrated in vacuo to ∼10
mL, and put into a -40 °C freezer. Deep red microcrystalline solid
was obtained after a few days; yield 658 mg (53%): 1H NMR (C6D6,
minor) δ 8.44 (d, Hâ, J ) 15.6), 6.9-7.7 (m, H’s of Ph’s), 4.30 (d, Hγ,
1
J ) 15.6), 0.34 (TMS); H NMR (C6D6, major) δ 7.34 (d, Hâ, J )
15.6), 6.9-7.7 (m, H’s of Ph’s), 5.78 (d, Hγ, J ) 15.6), 0.22 (TMS);
13C NMR (major, C6D6) δ 283.6, 1, 126.3 (JCH ) 150), 122.8 (JCH
)
150). Anal. Calcd for MoC39H47NO2F12Si: C, 51.26; H, 5.18; N, 1.53.
Found: C, 51.53; H, 5.52; N, 1.69.
Synthesis of Mo(NAd)(CMePh)[OCH(CF3)2]2(2,4-lutidine) (5a).
R-Methylstyrene (0.105 mL, 0.808 mmol) was added to an ether
solution of 2a (578 mg, 0.71 mmol). After 24 h the ether was removed
in vacuo to leave a dark yellow oily residue. Recrystallization of the
residue from pentane gave 5a as bright yellow microcrystals; yield 312
mg (56%): 1H NMR (C6D6) δ 8.45 (d, 1, 6, 2,4-Lut), 7.68 (dd, 2, J )
1.2, 8.4, Ph), 7.25 (m, 2, Ph), 7.01 (t , 1, Ph), 6.34 (sept, OCH(CF3)2),
6.17 (s, 1, 2,4-Lut), 6.02 (d, 1, 6), 4.51 (sept, 1, 6.3, OCH(CF3)2), 2.31
(s, 3, 2,4-Lut), 1.92 (br, 6, AdN), 1.76 (br, 3, AdN), 1.50 (br, 3, 2,4-
Lut), 1.34 (br, 6, AdN); 13C NMR (C6D6) δ 302.4 (CMe2Ph), 160.5
(2,4-Lut), 153.3 (2,4-Lut), 151.1 (Ph), 146.7 (2,4-Lut), 129.2 (Ph), 128.1
(Ph), 126.5 (Ph), 123.3 (2,4-Lut), 83.0 (OCH(CF3)2), 74.9, 74.5 (dNC),
43.6 (NAd), 36.0 (AdN), 29.7 (AdN), 27.4 (Me), 21.4 (Me); 19F NMR
(C6D6) δ -78.96 (1), -79.19 (1), -79.29 (1), -79.70 (1). Anal. Calcd
for MoC31H34N2O2F12: C, 47.01; H, 4.33; N, 3.54. Found: C, 47.26;
H, 4.44; N, 3.49.
Synthesis of Mo(NAd)(CPh2)[OCH(CF3)2]2(2,4-lutidine) (5b).
This compound was prepared in 46% yield by the same procedure as
that used to prepare 5a: 1H NMR (C6D6) δ 8.94 (d, 1, J ) 6), 7.50 (dt,
2, Ph), 7.10-7.26 (m, 6, Ph), 7.00 (m, 2), 6.23 (s, 1, 2,4-Lut), 6.10
(sept, 1, OCH(CF3)2), 6.09 (d, 1, 2,4-Lut), 4.82 (sept, 1, J ) 6.0,
OCH(CF3)2), 2.39 (s, 3, 2,4-Lut), 1.87 (q, 6, AdN), 1.75 (br, 3, AdN),
1.49 (s, 3, 2,4-Lut), 1.3 (s, 6, AdN); 13C NMR (C6D6) δ 310 (CPh2),
160.9, 153.0, 151.7, 151.2, 141.5, 129.5, 129.0, 128.6, 127.9, 127.38,
126.9, 123.2, 82.2 (OCH(CF3)2), 76.1 (dNC), 75.2 (OCH(CF3)2), 43.4
(NAd), 35.9 (NAd), 29.7 (NAd), 28.1 (Me, 2,4-Lut), 20.1 (Me, 2,4-
Lut); 19F NMR (C6D6) δ 73.57 (1), 74.43 (2), 74.52 (1). Anal. Calcd
for MoC36H36N2O2F12: C, 50.71; H, 4.26; N, 3.28. Found: C, 50.65;
H, 4.21; N, 3.31.
Synthesis of Mo(NAd)[C(Ph)C(Ph)CHCMe2Ph][OCH(CF3)2]2-
(2,4-lutidine) (6). To a cold (-40 °C) ether solution (∼60 mL) of 2a
(645 mg, 0.79 mmol) was added diphenylacetylene (142 mg, 0.80
mmol). The resulting yellow mixture was stirred at room temperature
for 6 h and then stripped of solvents in vacuum. The yellow solid
residue obtained was recrystallized from a toluene/pentane mixture to
afford 6 as a bright yellow microcrystalline solid; yield 530 mg
(67%): 1H NMR (C6D6) δ 8.75 (d, 1), 7.64 (d, 2), 6.80-7.40 (m, Ph’s),
6.20 (m, 1, OCH(CF3)2), 6.16 (d, 1), 6.14 (2H, m-H and CHCMe2Ph),
4.89 (m, 1, OCH(CF3)2), 2.30 (s, 3, o-Me), 1.76 (br, 6, CH2’s), 1.64
(br, 3, CH’s), 1.48 (br, 6, CH2’s), 1.29 (s, 3, p-Me), 1.22 (3, 6, CMe2-
Ph); 13C NMR (C6D6) δ 305.1, 160.4, 153.9, 150.9, 150.8, 149.4, 143.6,
Synthesis of Mo(N-2,6-i-Pr2C6H4)(CHCMe2Ph)[OCH(CF3)2]2(2,4-
lutidine) (8). This compound was synthesized in 74% yield by the
same procedure as that used to prepare 2a: 1H NMR (C6D6) δ 13.80
(s, 1H, CHCMe2Ph), 7.57 (d, 2H), 7.49 (d, 1H), 7.36 (t, 3H), 7.23 (t,
1H), 6.14 (s, 1H), 6.10 (d, 1H), 6.00 (m, 1H), 3.95 (m, 2H), 3.80 (m,
1H), 2.28 (s, 3H), 2.18 (s, 3H), 1.71 (s, 3H), 1.55 (s, 3H), 1.48 (d,
6H), 0.99 (d, 6H); 13C NMR (C6D6) δ 295.9 (CMe2Ph, JCH ) 127 Hz),
157.8, 156.3, 152.5, 151.0, 148.9, 147.8, 128.7, 17.8, 127.7, 126.5,
126.2, 123.82, 123.77, 77.4 (m, OCH(CF3)2), 75.6 (m, OCH(CF3)2),
54.6 (CMe2Ph), 31.4 (Me), 29.1 (Me), 28.1 (o-Me), 24.2 (Me), 24.1
(Me), 22.5, 20.1 (Me); 19F NMR (C6D6) δ -73.29, -73.88, -75.45,
-75.68. Anal. Calcd for MoC35H40N2O2F12: C, 49.77; H, 4.77; N,
3.32. Found: C, 49.91; H, 4.65; N, 3.10.
Photocatalyzed Isomerization of the Alkylidene Ligand in
Mo(NAd)[C(o-TMS-C6H4)(CHdCHCHCMe2Ph)][OCMe(CF3)2]2
(3a/b). A sample of the equilibrium mixture of 3a/b (71 mg, 0.078
mmol) and 6.8 µL of diphenylmethane (6.8 mg, 0.040 mmol) were
dissolved in 0.80 mL of toluene-d8. The deep red solution was then
irradiated with a medium-pressure Hg lamp at -60 °C. The concentra-
tion of the minor component increased at the expense of the major
product over a period of 24-48 h. The irradiated mixture was
immediately transferred to a precooled NMR probe, and the disap-
pearance of the minor product was followed by integration (TMS
group).
Insertion Studies with Catalyst 2a. Bulk toluene-d8 solutions of
catalyst 2a (64.7 mM) with Ph2CH2 (92.7 mM) as an internal standard
and monomers PA (2.6 M), o-MePA (2.1 M), o-i-PrPA (2.9 M), o-t-
BuPA (1.9 M) , and o-TMSPA (0.29 mL) were prepared. Typical
insertion studies were carried out by adding monomer to the catalyst
solution containing an internal standard (Ph2CH2). The catalyst
concentration was measured by integration of the alkylidene resonance
versus the CH2 resonance of Ph2CH2. The amount of the R product
was measured by the same method using the intensity of the Hâ and
Hγ resonances in the first insertion product, and the amount of the â
addition product using the intensity of new alkylidene resonances.
Polymerization of o-TMSPA by 2a. Stock toluene solutions were
prepared for both 2a (13.9 mM) and the monomer o-TMSPA (0.23
M). The polymerization reactions were carried out under dinitrogen
in a drybox by quick addition of the o-TMSPA solution to a vigorously
stirred solution of 2a at room temperature. In a typical experiment,